Teva Pharmaceutical Industries Limited (NYSE:TEVA) is set to announce third quarter earning results on Thursday 5th November 2020, before market open.
Analysts surveyed by Thomson Reuters are predicting, TEVA to report 3Q20 income of $ 0.58 per share.
For the full year, analysts anticipate top line of $ 16693.80 million, while looking forward to income of $ 2.51 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 16,600.00 million ~ $ 17,000.00 million, where as bottomline are predicted in a range of $ 2.30 ~ $ 2.55 per share
Click Here For More Historical Outlooks Of Teva Pharmaceutical Industries Limited
Previous Quarter Performance
Teva Pharmaceutical Industries Limited unfold income for the second quarter of $ 0.55 per share, from the revenue of $ 3,870.00 million. The quarterly earnings reduced 8.33 percent while revenues decreased 10.77 percent compared with the same quarter last year.
According to street consensus, TEVA was expected to report 2Q20 income of $ 0.53 per share from revenue of $ 3930.42 million. The bottom line results beat street analysts by $ 0.02 or 3.77 percent, at the same time, top line results fell short of analysts by $ 60.42 million or 1.54 percent.
Stock Performance
Shares of Teva Pharmaceutical Industries Limited traded up $ 0.33 or 3.72 percent on Wednesday, reaching $ 9.21 with volume of 9.52 million shares. Teva Pharmaceutical Industries Limited has traded high as $ 9.40 and has cracked $ 8.92 on the downward trend
The closing price of $ 9.21, representing a 42.08 % increase from the 52 week low of $ 6.25 and a 35.47 % decrease over the 52 week high of $ 13.76.
The company has a market capital of $ 10.29 billion and is part of the Healthcare sector and Drug Manufacturers – Specialty & Generic industry.
Conference Call
Teva Pharmaceutical Industries Limited will be hosting a conference call at 8:00 AM eastern time on 5th November 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.tevapharm.com
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. It operates through two segments, Generic Medicines and Specialty Medicines. The Generic Medicines segment offers sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams.
